eMedevents
  • 132744+ Medical Conferences
  • 251 Specialties
  • 34874 Organizers
  • 148791 Speakers
  • 155 Countries
  • 4471 Cities
44248+
CME Conference Registrations Sold
Home  >  Speakers  >  Patrick Y-s. Lam
Patrick Y-s. Lam

Patrick Y-s. Lam

    PhD
President, Professor | Doylesburg, Pennsylvania    United States of America
Biochemistry And Molecular Genetics
Biochemistry And Molecular Genetics, Cell Biology,...More
Spoken at 1 event

Biography :

Dr. Lam is a medicinal chemistry and drug discovery consultant. He currently collaborates with Blumberg scientists in terms of drug discovery and jointly supervises Blumberg chemistry postdocs and visiting scientists. Dr. Lam has 30 years of extensive experience in innovation in structure-based drug design, ADME, focused libraries, molecular recognition and nucleic acid therapeutics to deliver biopharma clinical candidates with novel profiles.

He is responsible for the discovery of a total of eight clinical candidates. At Bristol Myers Squibb, Dr. Lam was the group leader/co-inventor responsible for the discovery of Eliquis®/Apixaban, a novel Factor Xa anticoagulant recently launched on the market. Eliquis® is projected by analysts to be a transformational medicine with “block-buster” sales potential. Eliquis® was chosen as the “Best New Medicine of 2012” by Med Ad News. He and his team were awarded 2015 American Chemical Society Heroes of Chemistry Award for the discovery of Eliquis®. Dr. Lam is also the inventor of the novel cyclic urea class of HIV protease inhibitors that resulted in Mozenavir/DMP450. In Phase II clinical trial, Mozenavir was shown to be as efficacious as Merck’s Crixivan, but without the lipodystrophy side effect of Crixivan.

************************
*************
 
For speaker's contact information - Contact us

Specialties

Biochemistry and Molecular Genetics

Interested Topics

Biochemistry and Molecular Genetics, Cell Biology, Molecular Biology, Biotechnology, Molecular Recognition

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English, Chinese

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message